HRT Financial’s Nasus Pharma NSRX Stock Holding History

HRT Financial’s Portfolio NSRX Stock Details NSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38,897	Closed	-$86K	–	5727
2026 Q1	$86K	Buy	+38,897	New	+$201K	﹤0.01%	3377

Other funds holding NSRX

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

HRT Financial's NSRX Position: Q2 2026 in Review

HRT Financial sold out of Nasus Pharma (NSRX) in Q2 2026, closing a stake of 38,897 shares — an estimated $86K sold.

HRT Financial first reported a position in NSRX in Q1 2026 and held it in 1 quarter. The position peaked at $86K in Q1 2026. 10 funds tracked by Wall St. Rank hold NSRX as of Q2 2026.

HRT Financial reported no remaining Nasus Pharma position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 38,897 Nasus Pharma shares in Q2 2026, an estimated $86K.
HRT Financial first reported a position in Nasus Pharma in Q1 2026 and held it in 1 quarter.
HRT Financial's Nasus Pharma position peaked at $86K in Q1 2026.
10 funds tracked by Wall St. Rank held Nasus Pharma as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.